Current management of oligometastatic lung cancer and future perspectives: Results of thermal ablation as a local ablative therapy Review


Authors: Ghosn, M.; Solomon, S. B.
Review Title: Current management of oligometastatic lung cancer and future perspectives: Results of thermal ablation as a local ablative therapy
Abstract: A growing body of evidence shows improved overall survival and progression‐free survival after thermal ablation in non‐small cell lung carcinoma (NSCLC) patients with a limited number of metastases, combined with chemotherapy or tyrosine kinase inhibitors or after local recur-rence. Radiofrequency ablation and microwave ablation are the most evaluated modalities, and target tumor size <3 cm (and preferably <2 cm) is a key factor of technical success and efficacy. Although thermal ablation offers some advantages over surgery and radiotherapy in terms of repeat-ability, safety, and quality of life, optimal management of these patients requires a multidisciplinary approach, and further randomized controlled trials are required to help refine patient selection cri-teria. In this article, we present a comprehensive review of available thermal ablation modalities and recent results supporting their use in oligometastatic and oligoprogressive NSCLC disease along with their potential future implications in the emerging field of immunotherapy. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords: lung cancer; metastases; cryoablation; radiofrequency ablation; microwave ablation
Journal Title: Cancers
Volume: 13
Issue: 20
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2021-10-01
Start Page: 5202
Language: English
DOI: 10.3390/cancers13205202
PROVIDER: scopus
PMCID: PMC8534236
PUBMED: 34680348
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Solomon
    422 Solomon
  2. Mario Ghosn
    15 Ghosn